Novo Holdings leads USD118m Series C investment in Genomatica
Novo Holdings, a leading international life science investor, has led a USD118 million Series C financing in new portfolio company Genomatica, which harnesses biology to remake everyday products and materials with a reduced environmental impact. The funding will be used to accelerate the global commercialisation and expansion of Genomatica’s sustainable